MACSF

COMMUNIQUÉS West-GlobeNewswire

Unity Consortium Announces Publication of Journal of Adolescent Health Supplement: “Expert Perspectives on Evolving Adolescent Well Visits and Immunization Platforms”
28/07/2025
Supplement provides a timely and comprehensive review of adolescent immunization platforms, offering practical insights for healthcare providers navigating a shifting public health landscape VENTNOR CITY, N.J., July 28 [...]
Neurogen Biomarking Virtual Care Ecosystem Cuts Time to Alzheimer’s Intervention by 4.5 Years, AAIC 2025 Presentation Findings Show
28/07/2025
Progress in validating in-home blood test, combined with cognitive assessment and specialty virtual care, break through barriers to early detection Key Takeaways Findings from breakthrough approach to early detection [...]
How to Build Muscle Fast for Beginners And Skinny Guys: with CrazyBulk Legal Steroids for Muscle Endurance A Guide in 2025 For Bodybuilders Muscle Growth
28/07/2025
How to Build Muscle Fast for Beginners And Skinny Guys: with CrazyBulk Muscle-Building Supplements, The Ultimate Guide for 2025 Los Angeles, CA, July 28, 2025 (GLOBE NEWSWIRE) -- For beginners looking to build muscle [...]
SonderCare Launches Certified Home Hospital Beds to Support 16 Million Middle-Income Seniors Facing Long-Term Care Crisis
28/07/2025
Certified Premium Hospital Beds Offer Practical Solution for Families Navigating the "Missing Middle" of Senior Care London, ON , July 28, 2025 (GLOBE NEWSWIRE) -- SonderCare , a leading manufacturer of home-based [...]
Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
28/07/2025
CAMBRIDGE, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of [...]
Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress
28/07/2025
MET-097i (fully biased once-monthly GLP-1 RA) VESPER-1 and interim VESPER-3 data release expected in September 2025; Phase 3 initiation on track for late 2025 MET-233i (once-monthly amylin analog) delivered class- [...]
Celcuity Inc. Announces Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock
28/07/2025
MINNEAPOLIS, July 28, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced proposed [...]
Les Données de l'Étude Pivot DREAM de Nyxoah publiées dans le Journal of Clinical Sleep Medicine
28/07/2025
Les Données de l'Étude Pivot DREAM de Nyxoah publiées dans le Journal of Clinical Sleep Medicine Mont-Saint-Guibert, Belgique – 28 juillet 2025, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« [...]
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine
28/07/2025
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Mont-Saint-Guibert, Belgium – July 28, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “ [...]
Roivant to Report Financial Results for the First Quarter Ended June 30, 2025, and Provide Business Update on Monday, August 11, 2025
28/07/2025
BASEL, Switzerland and LONDON and NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, August 11, 2025, to [...]
AVITA Medical to Announce Second Quarter 2025 Financial Results
28/07/2025
VALENCIA, Calif. and MELBOURNE, Australia, July 28, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today [...]
iMDx to Host Virtual KOL Event to Discuss its In-House dd-cfDNA Testing for Kidney Transplant Patients on August 15, 2025
28/07/2025
NASHVILLE, Tenn., July 28, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics, or iMDx, (Nasdaq: IMDX), today announced that it will host a virtual key opinion leader (KOL) event on Friday, August 15, 2025 at 4:00 [...]
Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
28/07/2025
- Expected cash runway extended into Q3 2027, beyond multiple potential inflection points including Dyne’s first planned commercial launch in early 2027 - - Registrational Expansion Cohort of DELIVER Trial of DYNE-251 [...]
Abivax Announces Closing of $747.5 Million Public Offering
28/07/2025
Abivax Announces Closing of $747.5 Million Public Offering PARIS, France, July 28, 2025 – 10:15 p.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“ Abivax ” or the “ Company ”), a clinical-stage [...]
Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
28/07/2025
Informations Réglementées Châtillon, France, le 28 juillet (22 h 30 CET) 2025 Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq : [...]
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
28/07/2025
AMF Regulated Information Châtillon, France, July 28, 2025 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a [...]
Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering
28/07/2025
WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects the version issued on July 24, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is [...]
Cellectis publiera ses résultats financiers du deuxième trimestre 2025 le 4 août 2025
28/07/2025
NEW YORK, 28 juill. 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS) (la « Société »), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d'édition de génome [...]
Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025
28/07/2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell [...]

Pages